Breaking News Instant updates and real-time market news.

2022-08-12 07:05:15 RPID Rapid Micro Biosystems $4.21 / -0.03 (-0.71%) 07:05 08/12/22 08/12 07:05 08/12/22 07:05	Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction The Company is implementing an organizational restructuring plan to right-size its cost structure based on its lowered 2022 outlook. The Company will continue to invest in key growth initiatives including enhancing commercial execution and key product development programs that are expected to drive future revenue growth. The plan involves an approximately 20% reduction in the Company's workforce, which is largely focused on non-commercial functions. The Company expects the organizational restructuring plan to result in approximately $8.0 - $9.0 million in annualized cost savings by the first quarter 2023. It expects to incur restructuring charges of approximately $1.5 million to be recognized in the third quarter of fiscal year 2022.	12 Aug

2022-08-12 07:05:15

RPID

Rapid Micro Biosystems

$4.21 / -0.03 (-0.71%)

07:05

08/12/22

08/12

07:05

08/12/22

07:05

Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction

The Company is implementing an organizational restructuring plan to right-size its cost structure based on its lowered 2022 outlook. The Company will continue to invest in key growth initiatives including enhancing commercial execution and key product development programs that are expected to drive future revenue growth. The plan involves an approximately 20% reduction in the Company's workforce, which is largely focused on non-commercial functions. The Company expects the organizational restructuring plan to result in approximately $8.0 - $9.0 million in annualized cost savings by the first quarter 2023. It expects to incur restructuring charges of approximately $1.5 million to be recognized in the third quarter of fiscal year 2022.

12
Aug

OTHER BREAKING NEWS FROM THE FLY

Options	Cloudflare call volume above normal and directionally bullish » 11:45 12/09/22 12/09 11:45 12/09/22 11:45 NET Cloudflare $50.05 / +0.73 (+1.48%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NET Cloudflare $50.05 / +0.73 (+1.48%) 08/05/22 Cloudflare rises 16.4% 08/05/22 Cloudflare rises 15.2% NET Cloudflare $50.05 / +0.73 (+1.48%) 11/28/22 JPMorgan Cloudflare assumed with Neutral from Underweight at JPMorgan 11/08/22 Cloudflare participates in a conference call with Cantor Fitzgerald 11/07/22 Baird Cloudflare price target lowered to $67 from $80 at Baird 11/04/22 RBC Capital Cloudflare price target lowered to $60 from $74 at RBC Capital NET Cloudflare $50.05 / +0.73 (+1.48%) 11/03/22 Cloudflare raises FY22 EPS view to 11c-12c from 3c-4c, consensus 3c 11/03/22 Cloudflare sees Q4 adjusted EPS 4c-5c, consensus 1c 11/03/22 Cloudflare reports Q3 adjusted EPS 6c, consensus 0c 11/03/22 Notable companies reporting after market close NET Cloudflare $50.05 / +0.73 (+1.48%) 11/03/22 Fly Intel: After-Hours Movers 11/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/17/22 What You Missed On Wall Street On Monday 10/17/22 What You Missed On Wall Street This Morning NET Cloudflare $50.05 / +0.73 (+1.48%) 12/07/22 Cloudflare call volume above normal and directionally bullish 11/17/22 Cloudflare put volume heavy and directionally bearish 11/03/22 Cloudflare options imply 11.3% move in share price post-earnings 09/29/22 Cloudflare put volume heavy and directionally bearish
Conference/Events	Cadence Bank to participate in a conference call with Truist » 11:39 12/09/22 12/09 11:39 12/09/22 11:39 CADE Cadence Bank $26.12 / -0.25 (-0.95%) Analyst Demba holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CADE Cadence Bank $26.12 / -0.25 (-0.95%) 11/08/22 LPL Financial welcomes BancorpSouth to Institution Services Platform CADE Cadence Bank $26.12 / -0.25 (-0.95%) 12/05/22 Morgan Stanley Cadence Bank initiated with an Equal Weight at Morgan Stanley 11/17/22 Janney Montgomery Scott Cadence Bank downgraded to Neutral at Janney Montgomery Scott on valuation 11/17/22 Janney Montgomery Scott Cadence Bank downgraded to Neutral from Buy at Janney Montgomery Scott 07/11/22 Jefferies Cadence Bank price target lowered to $26 from $28 at Jefferies CADE Cadence Bank $26.12 / -0.25 (-0.95%) 10/24/22 Cadence Bank reports Q3 adjusted EPS 78c, consensus 07/25/22 Cadence Bank reports Q2 adjusted EPS 73c, consensus 64c 12:00 Today Cadence Bank - CADE
Periodicals	Toshiba's preferred bidder closer to securing financing, Reuters reports » 11:21 12/09/22 12/09 11:21 12/09/22 11:21 TOSYY Toshiba $16.20 / +0.11 (+0.68%) Toshiba's preferred… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TOSYY Toshiba $16.20 / +0.11 (+0.68%) 09/26/22 Accenture collaborates with Toshiba to drive emission reductions 07/06/22 Toshiba, Safe Quantum enter agreement to accelerate solutions in North America 06/28/22 Toshiba shareholders vote to add Elliott's Bhanji, Farallon's Imai to board TOSYY Toshiba $16.20 / +0.11 (+0.68%) 11/14/22 Jefferies Toshiba downgraded to Underperform from Hold at Jefferies 04/28/22 Jefferies Toshiba downgraded to Hold from Buy at Jefferies TOSYY Toshiba $16.20 / +0.11 (+0.68%) 10/11/22 Toshiba gives JIP-led group right of first refusal, Nikkei Asia reports 06/28/22 Toshiba working to narrow bidders down to 'handful,' WSJ reports 06/22/22 Toshiba bidders could offer up to $51.41 per share in buyout, Reuters reports TOSYY Toshiba $16.20 / +0.11 (+0.68%) 10/11/22 What You Missed On Wall Street This Morning 06/22/22 What You Missed On Wall Street On Wednesday 06/22/22 What You Missed On Wall Street This Morning
Hot Stocks	Pfizer raises quarterly cash dividend to 41c from 40c per share » 11:17 12/09/22 12/09 11:17 12/09/22 11:17 PFE Pfizer $51.86 / +0.06 (+0.12%) Pfizer announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $51.86 / +0.06 (+0.12%) 06:47 Today Pfizer, BioNTech get FDA FTD for mRNA-based combination vaccine candidate 12/08/22 Pfizer, BioNTech announce EUA for bivalent COVID vaccine for children under 5 12/07/22 Pfizer: FDA accepts for priority review BLA for RSV vaccine candidate, RSVpreF 12/06/22 Pfizer and Clear Creek Bio partnering on COVID-19 oral antiviral research PFE Pfizer $51.86 / +0.06 (+0.12%) 12/07/22 Piper Sandler Prometheus price target raised to $114 from $67 at Piper Sandler 11/17/22 Credit Suisse Pfizer initiated with an Outperform at Credit Suisse 11/15/22 BofA Moderna price target raised to $182 from $160 at BofA 11/03/22 KeyBanc Maravai Lifesciences price target lowered to $28 from $35 at KeyBanc PFE Pfizer $51.86 / +0.06 (+0.12%) 11/01/22 Pfizer raises FY22 adjusted EPS view to $6.40-$6.50 from $6.30-$6.45 11/01/22 Pfizer reports Q3 adjusted EPS $1.78, consensus $1.39 10/31/22 Notable companies reporting before tomorrow's open 10/31/22 Notable companies reporting before tomorrow's open PFE Pfizer $51.86 / +0.06 (+0.12%) 12/06/22 Pfizer dismisses Moderna claim it copied COVID-19 shot, CNBC reports 12/02/22 Pfizer to invest over $2.5B at Belgium, Ireland plants, Reuters reports 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports 11/03/22 General Mills, Mondelez, Pfizer halt Twitter advertising, WSJ reports PFE Pfizer $51.86 / +0.06 (+0.12%) 12/07/22 #SocialStocks: EU rules against Meta, despite attempts to settle 12/02/22 What You Missed On Wall Street On Friday 12/02/22 What You Missed On Wall Street This Morning 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 12/12/22 ASH Annual Meeting & Expo 2022 PFE Pfizer $51.86 / +0.06 (+0.12%) 11/14/22 Pfizer call volume above normal and directionally bullish 11/01/22 Unusually active option classes on open November 1st 10/21/22 Unusually active option classes on open October 21st 08/19/22 Early notable gainers among liquid option names on August 19th
Technical Analysis	NASDAQ market internals summary » 11:17 12/09/22 12/09 11:17 12/09/22 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 12/08/22 NASDAQ market internals summary 12/08/22 NASDAQ market internals summary 12/08/22 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 12/09/22 12/09 11:16 12/09/22 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 12/08/22 NYSE market internals summary 12/08/22 NYSE market internals summary 12/08/22 NYSE market internals summary
Hot Stocks	Phillips 66 announces 2023 capital program of $2B » 11:13 12/09/22 12/09 11:13 12/09/22 11:13 PSX Phillips 66 $99.18 / -1.82 (-1.80%) Phillips 66 announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PSX Phillips 66 $99.18 / -1.82 (-1.80%) 11/09/22 Phillips 66 to increase share repurchase program by $5B 10/17/22 Phillips 66 announces installation of FreeWire EV chargers in Houston 08/17/22 Phillips 66 proposing consideration of $34.75 per unit of DCP Midstream 08/17/22 Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31% PSX Phillips 66 $99.18 / -1.82 (-1.80%) 11/11/22 Wells Fargo Wells Fargo downgrades DCP Midstream on Phillips 66 offer 11/09/22 Piper Sandler Phillips 66 price target raised to $155 from $116 at Piper Sandler 11/03/22 Wells Fargo Phillips 66 price target raised to $134 from $123 at Wells Fargo 11/02/22 JPMorgan DCP Midstream downgraded to Neutral from Overweight at JPMorgan PSX Phillips 66 $99.18 / -1.82 (-1.80%) 11/01/22 Phillips 66 reports Q3 EPS $6.46, consensus $4.91 07/29/22 Phillips 66 reports Q2 adjusted EPS $6.77, consensus $5.78 PSX Phillips 66 $99.18 / -1.82 (-1.80%) 11/30/22 EPA to propose boost in biofuel quotas, Reuters reports 11/30/22 President Biden plans to boost biofuel quotas for next 3 years, Bloomberg says 11/14/22 Freeport LNG will likely cancel shipments through December, Bloomberg says 10/26/22 Phillips 66 begins staff cuts at refineries, terminals, offices, Reuters says PSX Phillips 66 $99.18 / -1.82 (-1.80%) 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning 06/15/22 What You Missed On Wall Street On Wednesday PSX Phillips 66 $99.18 / -1.82 (-1.80%) 10/07/22 Phillips 66 put volume heavy and directionally bearish 09/13/22 Phillips 66 call volume above normal and directionally bullish 09/02/22 Early notable gainers among liquid option names on September 2nd 06/13/22 Phillips 66 put volume heavy and directionally bearish
Recommendations	Piper says negative Cytokinetics FDA panel would be positive for shares » 11:12 12/09/22 12/09 11:12 12/09/22 11:12 CYTK Cytokinetics $36.95 / +0.95 (+2.64%) The FDA released briefing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CYTK Cytokinetics $36.95 / +0.95 (+2.64%) 09:03 Today Cytokinetics says FDA posted documents for meeting on omecamtiv mecarbil 12/08/22 Cytokinetics presents data at virtual International Symposium on ALS/MND 12/07/22 Cytokinetics initiates Phase 1 clinical study of CK-3828136 11/07/22 Cytokinetics presents new data at American Heart Association sessions CYTK Cytokinetics $36.95 / +0.95 (+2.64%) 10:21 Today H.C. Wainwright FDA releases briefing docs for Cytokinetics AdCom, says H.C. Wainwright 07:45 Today JPMorgan Cytokinetics price target lowered to $55 from $64 at JPMorgan 10/11/22 UBS Cytokinetics initiated with a Buy at UBS 08/15/22 Cantor Fitzgerald Cytokinetics price target raised to $69 from $56 at Cantor Fitzgerald CYTK Cytokinetics $36.95 / +0.95 (+2.64%) 11/03/22 Cytokinetics reports Q3 EPS ($1.52), consensus ($1.17) 08/04/22 Cytokinetics reports Q2 EPS (23c), consensus ($1.02) CYTK Cytokinetics $36.95 / +0.95 (+2.64%) 06/30/22 What You Missed On Wall Street This Morning 06/29/22 Fly Intel: After-Hours Movers 12/13/22 Cardiovascular and Renal Drugs Advisory Committee Meeting 02/28/23 Extended PDUFA Date for Omecamtiv
On The Fly	Biotech Alert: Searches spiking for these stocks today » 11:10 12/09/22 12/09 11:10 12/09/22 11:10 RXDX Prometheus $112.19 / -5.15 (-4.39%) , REPL Replimune Group $24.83 / +0.68 (+2.82%) , IBIO iBio / + , ESPR Esperion $5.75 / -0.43 (-6.96%) , SNDX Syndax $20.82 / -0.235 (-1.12%) These names in the… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options RXDX REPL IBIO ESPR SNDX RXDX Prometheus $112.19 / -5.15 (-4.39%) 12/07/22 Prometheus announces results for PRA023 in APOLLO-CD Phase 2 study 12/07/22 Prometheus announces results for PRA023 in ARTEMIS-UC Phase 2 study 10/03/22 Prometheus receives FDA clearance of IND application for PRA052 07/18/22 Prometheus completes enrollment of the ARTEMIS-UC cohort 1 phase 2 study REPL Replimune Group $24.83 / +0.68 (+2.82%) 12/07/22 Replimune Group announces updates on RP2/3 data, development plans 12/07/22 Replimune Group announces initial data from IGNYTE trial on RP1 12/07/22 Replimune Group enters collaboration agreement with Roche 11/03/22 Replimune Group: Financing extends cash runway into 2025 IBIO iBio / + 12/02/22 iBio announces resignation of CEO Thomas Isett 11/03/22 iBio seeking to divest its contract development, manufacturing organization 09/27/22 iBio dives 34% to 21c per share after reporting FY22 preliminary revenue 09/27/22 iBio announces 1-for-25 reverse stock split ESPR Esperion $5.75 / -0.43 (-6.96%) 12/07/22 Esperion announces CLEAR cardiovascular outcomes trial of NEXLETOL 11/16/22 Esperion promotes Ben Halladay to CFO role 08/26/22 Esperion: NEXLETOL recommended as oral non-statin therapy by ACC task force 08/23/22 Point72 reports 5.2% passive stake in Esperion Therapeutics SNDX Syndax $20.82 / -0.235 (-1.12%) 12/05/22 Syndax: FDA grants Breakthrough Therapy Designation for revumenib 12/05/22 Syndax, Incyte report axatilimab Phase 1/2 data 12/02/22 Syndax names Steve Sabus as Chief Commercial Officer 11/03/22 Syndax lowers FY22 research and development expenses view to $115M-$125M RXDX REPL IBIO ESPR SNDX RXDX Prometheus $112.19 / -5.15 (-4.39%) 12/08/22 RBC Capital Prometheus price target raised to $111 from $66 at RBC Capital 12/08/22 Credit Suisse Prometheus price target raised to $142 from $59 at Credit Suisse 12/08/22 Wells Fargo Prometheus price target raised to $164 from $71 at Wells Fargo 12/08/22 BTIG Prometheus price target raised to $181 from $74 at BTIG REPL Replimune Group $24.83 / +0.68 (+2.82%) 10/14/22 BMO Capital Replimune Group price target raised to $40 from $30 at BMO Capital 08/16/22 Piper Sandler Replimune Group price target lowered to $43 from $44 at Piper Sandler 05/24/22 Wedbush Replimune Group price target lowered to $52 from $59 at Wedbush 05/19/22 Piper Sandler Replimune Group price target lowered to $44 from $52 at Piper Sandler IBIO iBio / + 10/06/22 Cantor Fitzgerald iBio downgraded to Neutral from Overweight at Cantor Fitzgerald ESPR Esperion $5.75 / -0.43 (-6.96%) 12/07/22 H.C. Wainwright H.C. Wainwright bullish on Esperion as CLEAR Outcomes meets primary endpoint 08/03/22 Credit Suisse Esperion downgraded to Underperform from Neutral at Credit Suisse 05/04/22 JPMorgan Esperion upgraded to Neutral on achievable estimates at JPMorgan 05/04/22 JPMorgan Esperion upgraded to Neutral from Underweight at JPMorgan SNDX Syndax $20.82 / -0.235 (-1.12%) 09/20/22 B. Riley B. Riley replaces Allogene with Syndax as top pick for 2022 07/28/22 B. Riley Syndax resumed with a Buy at B. Riley 04/11/22 H.C. Wainwright Syndax initiated with a Buy at H.C. Wainwright 02/14/22 Goldman Sachs Syndax initiated with a Buy at Goldman Sachs RXDX REPL IBIO ESPR SNDX RXDX Prometheus $112.19 / -5.15 (-4.39%) 11/09/22 Prometheus reports Q3 EPS (90c) vs. (70c) in Q321 08/11/22 Prometheus reports Q2 EPS (86c), consensus (91c) REPL Replimune Group $24.83 / +0.68 (+2.82%) 11/03/22 Replimune Group reports Q2 EPS (79c), consensus (78c) 08/04/22 Replimune Group reports Q1 EPS (78c) vs (53c) last year IBIO iBio / + 09/27/22 iBio reports FY22 revenue $2.4M, two estimates, $2.55M ESPR Esperion $5.75 / -0.43 (-6.96%) 11/01/22 Esperion reports Q3 EPS (81c), consensus (92c) 08/02/22 Esperion reports Q2 EPS ($1.05), consensus (93c) SNDX Syndax $20.82 / -0.235 (-1.12%) 11/03/22 Syndax reports Q3 EPS (58c), consensus (63c) 08/08/22 Syndax reaffirms FY22 research and development expenses view $130M-$140M 08/08/22 Syndax sees Q3 research and development expenses $25M-$30M 08/08/22 Syndax reports Q2 EPS (62c), consensus (65c) 09 Dec 09 Dec 07 Dec 07 Dec 16 Dec RXDX IBIO ESPR SNDX RXDX Prometheus $112.19 / -5.15 (-4.39%) 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 What You Missed On Wall Street This Morning 07/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations IBIO iBio / + 09/27/22 Fly Intel: After-Hours Movers ESPR Esperion $5.75 / -0.43 (-6.96%) 08/03/22 What You Missed On Wall Street On Wednesday 08/03/22 What You Missed On Wall Street This Morning 08/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SNDX Syndax $20.82 / -0.235 (-1.12%) 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 What You Missed On Wall Street This Morning 10/10/22 Biotech Alert: Searches spiking for these stocks today 12/14/22 Biotech/Biopharma 12/12/22 ASH Annual Meeting & Expo 2022 01/08/23 Syndax RXDX IBIO ESPR RXDX Prometheus $112.19 / -5.15 (-4.39%) 12/05/22 Prometheus Biosciences put volume heavy and directionally bearish 11/22/22 Unusually active option classes on open November 22nd IBIO iBio / + 09/27/22 iBio options imply 58.6% move in share price post-earnings ESPR Esperion $5.75 / -0.43 (-6.96%) 12/07/22 Unusually active option classes on open December 7th 11/17/22 Largest borrow rate increases among liquid names
Hot Stocks	Crypto 1 Acquisition plans to dissolve, liquidate » 11:01 12/09/22 12/09 11:01 12/09/22 11:01 DAOO Crypto 1 Acquisition $10.14 / + (+0.00%) As of the close of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Conference/Events	Canadian National management to meet with Desjardins » 10:55 12/09/22 12/09 10:55 12/09/22 10:55 CNI Canadian National $125.64 / -0.31 (-0.25%) Group luncheon meeting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CNI Canadian National $125.64 / -0.31 (-0.25%) 12/07/22 North American rail traffic down 1.7% for the week ending December 3 12/02/22 White House announces signing of railroad dispute resolution 11/30/22 North American rail traffic up 2.4% for the week ending November 26 11/29/22 Rail union BMWED 'disappointed' in Biden proposal not including 'paid sick days' CNI Canadian National $125.64 / -0.31 (-0.25%) 11/29/22 BofA Canadian National price target raised to $140 from $131 at BofA 10/26/22 BMO Capital Canadian National price target raised to C$180 from C$170 at BMO Capital 10/26/22 Scotiabank Canadian National price target raised to C$159 from C$156 at Scotiabank 10/26/22 Barclays Canadian National price target raised to $118 from $110 at Barclays CNI Canadian National $125.64 / -0.31 (-0.25%) 10/25/22 Canadian National raises FY22 adjusted EPS view to up 25% from up 15%-20% 10/25/22 Canadian National reports Q3 adjusted EPS C$2.13 vs. C$2.37 last year 07/26/22 Canadian National sees FY22 adjusted diluted EPS growth of 15%-20% 07/26/22 Canadian National reports Q2 EPS C$1.93, consensus C$1.76 CNI Canadian National $125.64 / -0.31 (-0.25%) 12/01/22 Senate approves bill to force tentative rail labor agreement, CNBC says 11/30/22 House passes bill to avoid rail strike, NBC News reports 11/28/22 Biden intends to call on Congress to prevent rail shutdown, WaPo says 11/10/22 Bank of Canada's Macklem says low unemployment rate unsustainable,' WSJ says CNI Canadian National $125.64 / -0.31 (-0.25%) 11/30/22 What You Missed On Wall Street On Wednesday 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 10/25/22 Fly Intel: After-Hours Movers 12:00 Today Canadian National 12:00 Today Canadian National
Upgrade	China Southern Airlines upgraded to Buy from Reduce at HSBC » 10:52 12/09/22 12/09 10:52 12/09/22 10:52 ZNH China Southern Airlines $32.67 / +0.17 (+0.52%) HSBC analyst Parash Jain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly ZNH China Southern Airlines $32.67 / +0.17 (+0.52%) 09/23/22 Airbus announces Xiamen Airlines switches to A320neo Family ZNH China Southern Airlines $32.67 / +0.17 (+0.52%) 11/01/22 HSBC China Southern Airlines downgraded to Reduce from Hold at HSBC 09/20/22 HSBC China Southern Airlines downgraded to Hold from Buy at HSBC 06/16/22 Jefferies China Southern Airlines downgraded to Underperform from Hold at Jefferies 06/06/22 Daiwa China Southern Airlines upgraded to Buy from Hold at Daiwa ZNH China Southern Airlines $32.67 / +0.17 (+0.52%) 10/30/22 China Southern cancels planned return of Boeing 737 MAX flights, Reuters says ZNH China Southern Airlines $32.67 / +0.17 (+0.52%) 10/31/22 What You Missed On Wall Street On Monday 10/31/22 What You Missed On Wall Street This Morning
Upgrade	Air China upgraded to Buy from Reduce at HSBC » 10:51 12/09/22 12/09 10:51 12/09/22 10:51 AICAF Air China / + HSBC analyst Parash Jain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AICAF Air China / + 09/20/22 HSBC Air China downgraded to Reduce from Hold at HSBC 09/07/22 JPMorgan Air China upgraded to Overweight from Neutral at JPMorgan 06/16/22 Jefferies Air China downgraded to Underperform from Hold at Jefferies 03/23/22 Jefferies Air China downgraded to Hold from Buy at Jefferies
Hot Stocks	Elanco announces FDA approval of Bexacat » 10:50 12/09/22 12/09 10:50 12/09/22 10:50 ELAN Elanco $12.62 / +0.075 (+0.60%) Elanco Animal Health… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ELAN Elanco $12.62 / +0.075 (+0.60%) 11/14/22 Starboard takes stake in Wix.com, exits Elanco Animal Health 11/07/22 Notable companies reporting before tomorrow's open 11/07/22 Notable companies reporting before tomorrow's open 09/09/22 Elanco reports Sachem Head's Scott Ferguson stepping down from board ELAN Elanco $12.62 / +0.075 (+0.60%) 11/14/22 Piper Sandler Elanco price target lowered to $15 from $21 at Piper Sandler 10/17/22 JPMorgan Elanco price target lowered to $20 from $24 at JPMorgan 09/12/22 Barclays Elanco price target lowered to $18 from $32 at Barclays 08/18/22 Morgan Stanley Elanco downgraded to Equal Weight from Overweight at Morgan Stanley ELAN Elanco $12.62 / +0.075 (+0.60%) 11/08/22 Elanco lowers FY22 adjusted EPS view to $1.01-$1.07 from $1.06-$1.13 11/08/22 Elanco reports Q3 adjusted EPS 20c, consensus 16c 08/08/22 Elanco sees Q3 adjusted EPS 12c-18c, consensus 26c 08/08/22 Elanco lowers 2022 adjusted EPS view to $1.06-$1.13 from $1.15-$1.21 ELAN Elanco $12.62 / +0.075 (+0.60%) 09/09/22 What You Missed On Wall Street On Friday 09/09/22 What You Missed On Wall Street This Morning 08/18/22 Fly Intel: Pre-market Movers 08/08/22 What You Missed On Wall Street On Monday ELAN Elanco $12.62 / +0.075 (+0.60%) 09/16/22 Elanco Animal Health call volume above normal and directionally bullish 09/14/22 Elanco Animal Health call volume above normal and directionally bullish 09/13/22 Elanco Animal Health call volume above normal and directionally bullish 09/09/22 Unusually active option classes on open September 9th
Hot Stocks	Abbott board increases quarterly dividend 8.5% to 51c per share » 10:50 12/09/22 12/09 10:50 12/09/22 10:50 ABT Abbott $107.43 / +0.475 (+0.44%) Abbott announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABT Abbott $107.43 / +0.475 (+0.44%) 10/19/22 Abbott says 'don't need to do M&A,' but lots of opportunities exist 10/19/22 Abbott says macro economic conditions 'remain challenging' 10/19/22 Abbott reports Q3 U.S. Medical Devices sales grew 11.3% 10/19/22 Abbott 'particularly pleased' with sales growth rates in U.S. Medical Devices ABT Abbott $107.43 / +0.475 (+0.44%) 12/01/22 Wolfe Research Wolfe Research cuts Edwards Lifesciences to Peer Perform on macro, TAVR maturity 11/16/22 Evercore ISI Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list 10/26/22 Mizuho Abbott initiated with a Neutral at Mizuho 10/21/22 Barclays Abbott post-earnings selloff seems overdone, says Barclays ABT Abbott $107.43 / +0.475 (+0.44%) 10/19/22 Abbott sees Q4 EPS 86c-92c, consensus 95c 10/19/22 Abbott sees Q4 revenue growth mid single digits, consensus $9.65B 10/19/22 Abbott says FY22 guidance assumes COVID-19 testing-related sales of $7.8B 10/19/22 Abbott raises FY22 adjusted EPS view to 5.17-$5.23 from at least $4.90 ABT Abbott $107.43 / +0.475 (+0.44%) 08/28/22 Abbott restarts infant formula production at Michigan facility, Reuters says 07/10/22 Abbott reopens Michigan baby formula plant, Reuters reports 06/16/22 Abbott halts production at baby formula plant following storms, WSJ reports ABT Abbott $107.43 / +0.475 (+0.44%) 10/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/19/22 What You Missed On Wall Street On Wednesday 10/19/22 What You Missed On Wall Street This Morning 10/19/22 Fly Intel: Pre-market Movers 02/14/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference ABT Abbott $107.43 / +0.475 (+0.44%) 11/28/22 Abbott put volume heavy and directionally bearish 10/07/22 Early notable gainers among liquid option names on October 7th 10/06/22 Abbott call volume above normal and directionally bullish 06/22/22 Abbott put volume heavy and directionally bearish
General news	Looking ahead: all eyes will be on the FOMC outcome » 10:50 12/09/22 12/09 10:50 12/09/22 10:50 $ECON Economic Data / + Looking ahead: all eyes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says 10/10/22 JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months 09/07/22 Fed Beige Book says price levels 'remained highly elevated' $ECON Economic Data / + 11/30/22 What You Missed On Wall Street On Wednesday 11/28/22 What You Missed On Wall Street On Monday 11/28/22 What You Missed On Wall Street This Morning 11/02/22 What You Missed On Wall Street On Wednesday
Periodicals	Juul set to pay $1.2B as part of youth vaping settlement, Bloomberg reports 10:49 12/09/22 12/09 10:49 12/09/22 10:49 MO Altria Group $46.86 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MO Altria Group $46.86 / + (+0.00%) 12/07/22 Juul settles over 5,000 vaping suits in global resolution 10/27/22 Altria Group announces partnership with JT Group 10/20/22 Philip Morris to pay $2.7B to Altria Group to end IQOS commercial relationship 10/19/22 Philip Morris acquires U.S. commercialization rights to IQOS from Altria MO Altria Group $46.86 / + (+0.00%) 11/10/22 UBS UBS downgrades Altria to Sell on consumer trade down risk 11/10/22 UBS Altria Group downgraded to Sell from Neutral at UBS 11/02/22 Morgan Stanley Philip Morris price target raised to $109 from $102 at Morgan Stanley 10/28/22 Stifel Altria JV news trumps 'rare' EPS miss, says Stifel MO Altria Group $46.86 / + (+0.00%) 10/27/22 Altria Group narrows FY22 EPS view to $4.81-$4.89, consensus $4.85 10/27/22 Altria Group reports Q3 adjusted EPS $1.28, consensus $1.30 07/28/22 Altria Group backs FY22 adjusted EPS view of $4.79-$4.93, consensus $4.83 07/28/22 Altria Group reports Q2 adjusted EPS $1.26, consensus $1.25 MO Altria Group $46.86 / + (+0.00%) 10/25/22 Juu in talks for possible bailout with Hyatt heir, California investor, WSJ says 10/19/22 Philip Morris agrees to pay $2.7B to regain U.S. IQOS rights, WSJ says 10/19/22 Philip Morris to increase offer for Swedish Match, WSJ reports 10/04/22 Juul Labs starts talks over funding for potential bankruptcy, Bloomberg says MO Altria Group $46.86 / + (+0.00%) 11/10/22 Fly Intel: Pre-market Movers 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning 10/20/22 What You Missed On Wall Street On Thursday MO Altria Group $46.86 / + (+0.00%) 10/11/22 Altria Group call volume above normal and directionally bullish 10/11/22 Early notable gainers among liquid option names on October 11th 09/29/22 Altria Group call volume above normal and directionally bullish 09/23/22 Altria Group call volume above normal and directionally bullish
Upgrade	Health & Happiness upgraded to Buy from Hold at HSBC » 10:48 12/09/22 12/09 10:48 12/09/22 10:48 BTSDF Health & Happiness $1.40 / + (+0.00%) HSBC analyst Lina Yan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	Uber sues NYC Taxi comission over driver rate increases, Bloomberg reports » 10:47 12/09/22 12/09 10:47 12/09/22 10:47 UBER Uber $26.67 / +0.205 (+0.77%) , LYFT Lyft $10.88 / +0.235 (+2.21%) Uber (UBER) has filed a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 12/08/22 Walgreens Boots Alliance launches free Paxlovid delivery with DoorDash, Uber 12/07/22 Uber, Motional announce launch of public robotaxi service in Las Vegas 12/07/22 Motional and Uber to launch public autonomous robotaxi service in Las Vegas 12/05/22 Chicago announces $10M settlement with Uber over restaurant listings LYFT Lyft $10.88 / +0.235 (+2.21%) 11/03/22 Lyft: No change to Q3 revenue, margin, adjusted EBITDA guidance 11/03/22 Lyft confirms plans to terminate 13% of employees, or about 683 workers 11/02/22 Alaska Air announces new partnership with Lyft 10/24/22 Lyft re-introduces Lyft Pink membership with lower subscription price UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 12/02/22 RBC Capital DoorDash downgraded to Sector Perform from Outperform at RBC Capital 11/09/22 Wells Fargo Lyft price target lowered to $30 from $42 at Wells Fargo 11/09/22 Northcoast Lyft downgraded to Neutral on profitability challenges at Northcoast 11/08/22 BofA Lyft price target lowered to $11.50 from $14 at BofA LYFT Lyft $10.88 / +0.235 (+2.21%) 12/06/22 BTIG Lyft price target lowered to $15 from $25 at BTIG 12/05/22 Citi Lyft price target lowered to $45 from $57 at Citi 11/25/22 Argus Lyft price target lowered to $17 from $41 at Argus 11/21/22 Cowen Lyft downgraded to Market Perform at Cowen on macro and insurance headwinds UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 11/01/22 Uber reports Q3 EPS (61c), consensus (22c) 10/31/22 Notable companies reporting before tomorrow's open 10/31/22 Notable companies reporting before tomorrow's open 08/02/22 Uber reports Q2 EPS ($1.33), consensus (26c) LYFT Lyft $10.88 / +0.235 (+2.21%) 11/07/22 Lyft sees FY22 revenue $4.65B-$4.85B, consensus $4.08B 11/07/22 Lyft sees Q4 revenue $1.145B-$1.165B, consensus $1.17B 11/07/22 Lyft reports Q3 EPS ($1.18), consensus 7c 11/07/22 Notable companies reporting after market close UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 12/07/22 Australia fines Uber $14M for misleading customers, Reuters reports 11/17/22 UberEats wants to add thousands of NYC bodegas to delivery app, NY Post says 11/03/22 Uber whistleblower calls company's business model unsustainable, Reuters says 10/21/22 Instacart 'highly unlikely' to go public in 2022, WSJ reports LYFT Lyft $10.88 / +0.235 (+2.21%) 11/03/22 Lyft plans to cut 13% of staff in second round of job cuts, WSJ reports 10/16/22 Lyft battles Newsom over California measure to fund EVs, WSJ reports 10/11/22 Lyft tests new pay algorithm, Reuters reports 09/27/22 Lyft to freeze all U.S. hiring through end of 2022, New York Post says UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 12/07/22 What You Missed On Wall Street This Morning 11/01/22 What You Missed On Wall Street On Tuesday 11/01/22 What You Missed On Wall Street This Morning 11/01/22 Fly Intel: Pre-market Movers LYFT Lyft $10.88 / +0.235 (+2.21%) 11/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/08/22 What You Missed On Wall Street On Tuesday 11/08/22 What You Missed On Wall Street This Morning 12/14/22 Internet Services UBER LYFT UBER Uber $26.67 / +0.205 (+0.77%) 11/01/22 Unusually active option classes on open November 1st 11/01/22 Notable open interest changes for November 1st 10/12/22 Notable open interest changes for October 12th 10/11/22 Unusually active option classes on open October 11th LYFT Lyft $10.88 / +0.235 (+2.21%) 11/29/22 Lyft call volume above normal and directionally bullish 11/23/22 Notable open interest changes for November 23rd 11/22/22 Lyft call volume above normal and directionally bullish 11/07/22 Lyft options imply 18.1% move in share price post-earnings
Options	Carvana call volume above normal and directionally bullish » 10:45 12/09/22 12/09 10:45 12/09/22 10:45 CVNA Carvana $5.30 / +0.35 (+7.07%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CVNA Carvana $5.30 / +0.35 (+7.07%) 09:47 Today Carvana falls -9.5% 12/08/22 Carvana rises 15.7% 12/08/22 Carvana rises 8.0% 12/07/22 Carvana falls -36.1% CVNA Carvana $5.30 / +0.35 (+7.07%) 08:39 Today Jefferies Vroom price target lowered to $1.10 from $1.30 at Jefferies 08:37 Today Jefferies Carvana price target lowered to $5 from $10 at Jefferies 06:26 Today Needham Needham downgrades Carvana, struggles to see near-term path forward 05:46 Today Needham Carvana downgraded to Hold from Buy at Needham CVNA Carvana $5.30 / +0.35 (+7.07%) 11/03/22 Carvana sees sequential reduction in retail units sold in Q4 11/03/22 Carvana reports Q3 EPS ($2.67), consensus ($1.94) 11/03/22 Notable companies reporting after market close 08/04/22 Carvana reports Q2 EPS ($2.35), consensus ($1.79) 22 Apr CVNA Carvana $5.30 / +0.35 (+7.07%) 12/07/22 Carvana talking to Kirkland, Moelis about restructuring debt, Bloomberg says 12/07/22 Carvana in talks with Moelis, Kirkland about debt restructuring, Bloomberg says 12/06/22 Apollo, Pimco sign deal to act together in Carvana debt talks, Bloomberg says 11/20/22 Carvana facing cash crunch from high debt, interest rates, WSJ says CVNA Carvana $5.30 / +0.35 (+7.07%) 09:32 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 What You Missed On Wall Street This Morning 12/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CVNA Carvana $5.30 / +0.35 (+7.07%) 08:45 Today Largest borrow rate increases among liquid names 12/08/22 Notable open interest changes for December 8th 12/01/22 Carvana call volume above normal and directionally bullish 11/16/22 Carvana put volume heavy and directionally bearish

General news	The preliminary Michigan sentiment headline bounce » 10:35 12/09/22 12/09 10:35 12/09/22 10:35 $ECON Economic Data / + The preliminary Michigan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says 10/10/22 JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months 09/07/22 Fed Beige Book says price levels 'remained highly elevated' $ECON Economic Data / + 11/30/22 What You Missed On Wall Street On Wednesday 11/28/22 What You Missed On Wall Street On Monday 11/28/22 What You Missed On Wall Street This Morning 11/02/22 What You Missed On Wall Street On Wednesday
General news	Market Action: Treasury yields moved higher still » 10:35 12/09/22 12/09 10:35 12/09/22 10:35 $ECON Economic Data / + Market Action: Treasury… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says 10/10/22 JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months 09/07/22 Fed Beige Book says price levels 'remained highly elevated' $ECON Economic Data / + 11/30/22 What You Missed On Wall Street On Wednesday 11/28/22 What You Missed On Wall Street On Monday 11/28/22 What You Missed On Wall Street This Morning 11/02/22 What You Missed On Wall Street On Wednesday
Hot Stocks	IBM Canada to open Client Innovation Centre in Fredericton » 10:33 12/09/22 12/09 10:33 12/09/22 10:33 IBM IBM $147.51 / -0.31 (-0.21%) IBM Canada announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options IBM IBM $147.51 / -0.31 (-0.21%) 12/07/22 IBM to acquire Octo from Arlington Capital Partners, terms not disclosed 12/07/22 IBM to acquire Octo, terms not disclosed 11/30/22 IBM, Maersk to discontinue blockchain-enabled supply chain project TradeLens 11/16/22 Northrop Grumman names IBM CEO Krishna to board of directors IBM IBM $147.51 / -0.31 (-0.21%) 10/18/22 BofA IBM price target lowered to $145 from $155 at BofA 10/17/22 Northland Salesforce initiated with a Market Perform at Northland 10/17/22 Stifel IBM price target lowered to $140 from $150 at Stifel 10/06/22 Morgan Stanley IBM price target lowered to $152 from $155 at Morgan Stanley IBM IBM $147.51 / -0.31 (-0.21%) 10/19/22 IBM reports Q3 Software revenue $5.8B, up 14.2% in constant currency 10/19/22 IBM sees FY22 constant currency revenue growth above mid-single digit model 10/19/22 IBM reports Q3 adjusted EPS $1.81, consensus $1.77 10/19/22 Notable companies reporting after market close IBM IBM $147.51 / -0.31 (-0.21%) 11/11/22 IBM partners with new semiconductor company, FT reports 11/09/22 IBM engaged in talks with White House over quantum controls, Bloomberg says 09/17/22 IBM, CVS among cheap stocks not deserving to be in bargain bin, Barron's says 08/02/22 IBM board investigating suit's claims of manipulated sales, The Register says IBM IBM $147.51 / -0.31 (-0.21%) 10/20/22 What You Missed On Wall Street On Thursday 10/20/22 What You Missed On Wall Street This Morning 10/20/22 Fly Intel: Pre-market Movers 10/19/22 Fly Intel: After-Hours Movers IBM IBM $147.51 / -0.31 (-0.21%) 10/20/22 Early notable gainers among liquid option names on October 20th 10/19/22 IBM options imply 5.0% move in share price post-earnings 09/13/22 IBM put volume heavy and directionally bearish 08/01/22 IBM call volume above normal and directionally bullish
Hot Stocks	Microsoft acquires fiber solutions provider Lumenisity » 10:33 12/09/22 12/09 10:33 12/09/22 10:33 MSFT Microsoft $244.87 / -2.54 (-1.03%) Microsoft announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $244.87 / -2.54 (-1.03%) 12/08/22 Activision Blizzard CEO confident Microsoft deal will close 12/08/22 Microsoft's Smith has 'complete confidence' in case regarding Activision deal 12/08/22 FTC announces suit seeking to block Microsoft from buying Activision 12/08/22 Activision falls 2% to $74.05 after Bloomberg report of FTC suit MSFT Microsoft $244.87 / -2.54 (-1.03%) 12/08/22 Citi DoD contracts shows competitiveness of cloud industry, says Citi 12/07/22 BTIG SentinelOne price target lowered to $20 from $25 at BTIG 12/01/22 BMO Capital Okta price target raised to $69 from $58 at BMO Capital 12/01/22 Wedbush Activision Blizzard added to Best Ideas List at Wedbush MSFT Microsoft $244.87 / -2.54 (-1.03%) 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 10/25/22 Notable companies reporting after market close 07/26/22 Microsoft sees FY23 revenue growth in double digits, consensus $225.98B MSFT Microsoft $244.87 / -2.54 (-1.03%) 12/08/22 Microsoft says Riot Games content coming to Game Pass December 12 12/08/22 FTC votes to sue Microsoft over Activision acquisition, Bloomberg says 12/08/22 FTC voted for suit to block Activision takeover, Bloomberg reports 12/08/22 FTC to sue Microsoft over Activision deal as soon as today, Bloomberg says MSFT Microsoft $244.87 / -2.54 (-1.03%) 08:56 Today Fly Intel: Pre-market Movers 12/08/22 What You Missed On Wall Street On Thursday 12/07/22 What You Missed This Week in Video Games 12/06/22 What You Missed On Wall Street On Tuesday 12/13/22 Microsoft Corp. MSFT Microsoft $244.87 / -2.54 (-1.03%) 11/10/22 Microsoft put buyer realizes 13% same-day gains 10/25/22 Microsoft options imply 3.9% move in share price post-earnings 09/16/22 Microsoft put buyer realizes 22% same-day gains 09/15/22 $6M Put buyer scoops up Microsoft Oct 225s
Options	Tal Education Group call volume above normal and directionally bullish » 10:25 12/09/22 12/09 10:25 12/09/22 10:25 TAL TAL Education $6.52 / +0.49 (+8.13%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options TAL TAL Education $6.52 / +0.49 (+8.13%) 10/28/22 TAL Education rises 10.8% 10/26/22 TAL Education rises 17.6% 10/24/22 TAL Education falls -19.5% 10/10/22 TAL Education falls -11.9% TAL TAL Education $6.52 / +0.49 (+8.13%) 11/03/22 UBS TAL Education upgraded to Buy at UBS, says Q2 profit 'start of stabilization' 11/03/22 UBS TAL Education upgraded to Buy from Neutral at UBS 10/31/22 CICC TAL Education upgraded to Outperform from Market Perform at CICC 10/31/22 BofA TAL Education upgraded to Neutral from Underperform at BofA TAL TAL Education $6.52 / +0.49 (+8.13%) 08/25/22 U.S., China near deal that may prevent Chinese company delistings, WSJ says TAL TAL Education $6.52 / +0.49 (+8.13%) 11/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/25/22 What You Missed On Wall Street On Thursday 08/25/22 What You Missed On Wall Street This Morning TAL TAL Education $6.52 / +0.49 (+8.13%) 10/28/22 Unusually active option classes on open October 28th 10/04/22 TAL Education Group (ADR) call volume above normal and directionally bullish 09/26/22 Unusually active option classes on open September 26th 08/30/22 Tal Education Group call buyer realizes 37% same-day gains

Events

Earnings calls, analyst events, roadshows and more

CADE
Today at 12:00

Cadence Bank - CADE Conference Calls
NTNX
Today at 12:00

Nutanix, Inc. Firm Sponsored Meetings
CNI
Today at 12:00

Canadian National Firm Sponsored Meetings

Montreal
CNI
Today at 12:00

Canadian National Firm Sponsored Meetings

Montreal
SOL
Today at 13:00

ReneSola Ltd. Firm Sponsored Meetings

5000 Hopyard Rd. Suite 302, Pleasanton, CA
Tomorrow at 00:00

San Antonio Breast Cancer Symposium: SABCS 2022 Conferences

Henry B. Gonzalez Convention Center, San Antonio, TX
ACET ...
Tomorrow at 00:00

ASH Annual Meeting & Expo 2022 Conferences

New Orleans, LA
Tomorrow at 00:00

Biotechnology--Dinner Industry Meetings

New Orleans, LA
Tomorrow at 00:00

Healthcare--Luncheon Industry Meetings

New Orleans, LA
Tomorrow at 18:00

Healthcare--Reception Industry Meetings

Preservation Hall--726 St. Peter, New Orleans, LA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	TOPS X TOPS TOP Ships Spot Secondary Managers: Maxim Priced at: $2.00 6.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KWE X KWE KWESST Micro Systems IPO Managers: ThinkEquity Priced at: $4.13 2.5M Shares ADMA X ADMA ADMA Biologics Spot Secondary Managers: Raymond James, Cantor Fitzgerald & Mizuho Priced at: $2.86 21M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CLFD X CLFD Clearfield Spot Secondary Managers: Cowen & Needham Priced at: $100.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IBIO X IBIO iBio Spot Secondary Managers: H.C. Wainwright Priced at: $1.04 3.65M Shares SNDX X SNDX Syndax Spot Secondary Managers: Goldman Sachs, JPMorgan & Cowen Priced at: $22.00 6.82M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XFOR X XFOR X4 Pharmaceuticals Spot Secondary Managers: Piper Sandler, Stifel & Cantor Fitzgerald Priced at: $1.10 52.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	VOR X VOR Vor Bio Spot Secondary Managers: Evercore ISI, Stifel & Oppenheimer Priced at: $4.30 15.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ABC X ABC AmerisourceBergen Block Trade Managers: JPMorgan Priced at: $166.00 4.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LESL X LESL Leslie's Block Trade Managers: Goldman Sachs Priced at: $12.10 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ERAS X ERAS Erasca Secondary Managers: JPMorgan & Goldman Sachs Priced at: $6.50 15.4M Shares REPL X REPL Replimune Group Secondary Managers: JPMorgan & SVB Securities Priced at: $23.50 5.37M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXDX X RXDX Prometheus Secondary Managers: Goldman Sachs, SVB Securities, Jefferies & Guggenheim Priced at: $110.00 4.55M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUTL X AUTL Autolus Therapeutics Spot Secondary Managers: Jefferies, William Blair & Wells Fargo Priced at: $2.00 75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GTLS X GTLS Chart Industries Spot Secondary Managers: Morgan Stanley & JPMorgan, BofA Priced at: $118.17 5.92M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	JEWL X JEWL Adamas One IPO Managers: Alexander Capital Priced at: $4.50 2.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access